000538 云南白药
已收盘 10-16 15:00:00
资讯
新帖
简况
云南白药（000538）10月14日主力资金净买入562.67万元
证券之星 · 10-15 09:08
云南白药（000538）10月14日主力资金净买入562.67万元
云南白药MSCI ESG评级上升至AA级
云南白药官微 · 10-13
云南白药MSCI ESG评级上升至AA级
中成药“药王”跌超13%！21个独家品种强势突围，云南白药、济川起飞，以岭、华润三九霸榜
米内网 · 10-12
中成药“药王”跌超13%！21个独家品种强势突围，云南白药、济川起飞，以岭、华润三九霸榜
鸟巢唱响“声命力”，气血与音乐同频——云南白药独家冠名周深鸟巢演唱会，以音乐共鸣探索健康理念年轻化表达
凤凰网港股 · 10-10
鸟巢唱响“声命力”，气血与音乐同频——云南白药独家冠名周深鸟巢演唱会，以音乐共鸣探索健康理念年轻化表达
云南白药营收净利创新高难掩增速滑坡，商业毛利率跌破6%，第二曲线有增长尚难接棒
证券之星 · 09-29
云南白药营收净利创新高难掩增速滑坡，商业毛利率跌破6%，第二曲线有增长尚难接棒
云南白药（000538）9月28日主力资金净买入3979.32万元
证券之星 · 09-29
云南白药（000538）9月28日主力资金净买入3979.32万元
股市必读：云南白药（000538）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：云南白药（000538）9月24日董秘有最新回复
云南白药：经营业绩逆势增长
证券之星 · 09-24
云南白药：经营业绩逆势增长
云南白药：应收账款增加主要来源于商业板块
证券之星 · 09-24
云南白药：应收账款增加主要来源于商业板块
云南白药：截至2026年二季度末，公司股东总数为189,362人
证券之星 · 09-24
云南白药：截至2026年二季度末，公司股东总数为189,362人
云南白药（000538）披露持股5%以上股东可交换债换股价格调整公告，9月22日股价上涨0.45%
证券之星 · 09-22
云南白药（000538）披露持股5%以上股东可交换债换股价格调整公告，9月22日股价上涨0.45%
云白国际回购2010万股，释放市场信心信号
投资观察 · 09-18
云白国际回购2010万股，释放市场信心信号
研报掘金丨中邮证券：首予云南白药云南白药，二线品种释放成长驱动力
格隆汇 · 09-17
研报掘金丨中邮证券：首予云南白药云南白药，二线品种释放成长驱动力
中邮证券：首次覆盖云南白药给予买入评级
证券之星 · 09-17
中邮证券：首次覆盖云南白药给予买入评级
云南白药：2026年特别分红权益分派实施公告
证券日报网 · 09-16
云南白药：2026年特别分红权益分派实施公告
套走6017万港元公款给自己买11只名表，万隆控股前行政总裁周泓获刑10年8个月
红星资本局 · 09-15
套走6017万港元公款给自己买11只名表，万隆控股前行政总裁周泓获刑10年8个月
云南白药获得发明专利授权：“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”
证券之星 · 09-11
云南白药获得发明专利授权：“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”
云南白药：9月7日接受机构调研，西部证券、招银理财参与
证券之星 · 09-08
云南白药：9月7日接受机构调研，西部证券、招银理财参与
云南白药上半年营收218.84亿元 拟现金分红18.52亿元
经济参考网 · 09-02
云南白药上半年营收218.84亿元 拟现金分红18.52亿元
诚通证券：给予云南白药增持评级
证券之星 · 08-31
诚通证券：给予云南白药增持评级
加载更多
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":53.08,"timestamp":1792134210000,"preClose":52.9,"halted":0,"volume":12910901,"delay":0,"changeRate":0.0034,"floatShares":1784000000,"shares":1784000000,"eps":2.9266,"marketStatus":"已收盘","change":0.18,"latestTime":"10-16 15:00:00","open":52.89,"high":53.66,"low":52.52,"amount":687000000,"amplitude":0.0216,"askPrice":53.08,"askSize":112,"bidPrice":53.05,"bidSize":2,"shortable":0,"etf":0,"ttmEps":2.9266,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792373400000},"marketStatusCode":5,"adr":0,"adjPreClose":52.9,"symbolType":"stock","openAndCloseTimeList":[[1792114200000,1792121400000],[1792126800000,1792134000000]],"highLimit":58.19,"lowLimit":47.61,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.3,"roa":"--","peRate":18.137087,"roe":"9.04%","epsLYR":2.89,"committee":-0.842558,"marketValue":94709000000,"turnoverRate":0.0072,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-20。","floatMarketCap":94702000000},"requestUrl":"/m/hq/s/000538/","defaultTab":"news","newsList":[{"id":"2675376757","title":"云南白药（000538）10月14日主力资金净买入562.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675376757?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:08","pubTimestamp":1792026495,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，云南白药报收于52.65元，上涨1.27%，换手率0.58%，成交量10.39万手，成交额5.46亿元。近5日资金流向一览见下表：云南白药融资融券信息显示，融资方面，当日融资买入3582.48万元，融资偿还4494.37万元，融资净偿还911.89万元。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500008066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","LU1993786604.SGD","BK0175","BK0239","BK0188","BK0196","LU1807302812.USD","BK0012","LU1960683339.HKD","BK0187","000538","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356069","title":"云南白药MSCI ESG评级上升至AA级","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356069","media":"云南白药官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675356069?lang=zh_cn&edition=full","pubTime":"2026-10-13 18:46","pubTimestamp":1791888360,"startTime":"0","endTime":"0","summary":"近日，国际权威指数机构摩根士丹利资本国际公司公布的最新ESG评级结果显示，云南白药集团股份有限公司MSCI的ESG评级从A级上升至AA级，创历史新高，跻身医药行业及云南省上市公司的领先梯队。云南白药已连续六年保持MSCI ESG评级A级及以上，本次评级提升标志着公司在环境、社会及公司治理领域的管理绩效获得国际评级机构的高度认可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-13/doc-inivasec7299575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PRXI","USXF","159717","IVRA","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674873664","title":"中成药“药王”跌超13%！21个独家品种强势突围，云南白药、济川起飞，以岭、华润三九霸榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2674873664","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674873664?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:27","pubTimestamp":1791793620,"startTime":"0","endTime":"0","summary":"销售额排名中，“三强”地位稳固，济川、扬子江独家品种起飞；增长方面冰火两重天，8个品种大跌超20%，13个品种逆势涨逾10%。中成药销售额TOP20中，阿胶、安宫牛黄丸、感冒灵颗粒稳居前三。其中，济川药业的独家品种蒲地蓝消炎口服液同比大涨14.71%，提升8个位次；扬子江药业的独家品种蓝芩口服液提升6个位次，云南白药的独家品种云南白药气雾剂提升3个位次等。13个中成药涨逾10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-12/doc-iniuyarc5366137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000538","BK0010","BK0188","BK0164","LU1807302812.USD","BK0012","BK0185","BK0183","BK0196","LU1993786604.SGD","BK0060","BK0187","BK0239","LU1960683339.HKD","BK0175","BK0028","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674481868","title":"鸟巢唱响“声命力”，气血与音乐同频——云南白药独家冠名周深鸟巢演唱会，以音乐共鸣探索健康理念年轻化表达","url":"https://stock-news.laohu8.com/highlight/detail?id=2674481868","media":"凤凰网港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674481868?lang=zh_cn&edition=full","pubTime":"2026-10-10 22:21","pubTimestamp":1791642060,"startTime":"0","endTime":"0","summary":"云南白药作为本次演唱会的独家冠名品牌，与数万\"生米\"共度了一场以音乐为名的中秋之约。当《想见到气血满满的你》在鸟巢唱响、全场齐声合唱，“气血声命力”也从一句传播主张，变成了万人同频的真实共鸣。一内一外之间，气血健康的认知被揉进了年轻人的日常。品牌也将生日应援延伸至城市空间，云南白药分别在长沙、昆明打造周深生日主题楼体，为歌迷提供共同庆生、打卡留念的场景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU5ODU1Mjg5Nw==&mid=2247836552&idx=3&sn=8503b4ade8e08090779b6ef285e1f149&chksm=ff1b4e4ea273d8b6ba9498c20d8e2684b0170c3af1e6e13666ae1ca96ceda829501bc28841ca&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0188","BK0175","BK0164","BK0196","BK0239","LU1807302812.USD","BK0012","BK0028","BK0187","PEJ","000538","LU1993786604.SGD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671299435","title":"云南白药营收净利创新高难掩增速滑坡，商业毛利率跌破6%，第二曲线有增长尚难接棒","url":"https://stock-news.laohu8.com/highlight/detail?id=2671299435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671299435?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:15","pubTimestamp":1790666123,"startTime":"0","endTime":"0","summary":"若剔除此项后，上半年归属净利润同比增长8.33%，二季度增速达到13.18%。证券之星注意到，尽管2026年上半年云南白药的营收、利润指标均创历史新高，但增速明显放缓。2023年中报，云南白药营收突破200亿元的规模，营收增幅12.73%，归属净利润增幅更是达88.47%。2024年上半年、2025年上半年，云南白药的营收增幅分别为0.72%、3.92%，归属净利润分别增长12.76%、13.93%，今年上半年归属净利润增速骤降至个位数。此外，云南白药布局创新药领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026092900019976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671690602","title":"云南白药（000538）9月28日主力资金净买入3979.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671690602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671690602?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:08","pubTimestamp":1790644126,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，云南白药报收于50.33元，上涨0.92%，换手率0.39%，成交量6.99万手，成交额3.51亿元。近5日资金流向一览见下表：云南白药融资融券信息显示，融资方面，当日融资买入1412.67万元，融资偿还1670.75万元，融资净偿还258.07万元。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0164","BK0012","BK0188","000538","LU1960683339.HKD","BK0187","BK0196","LU1993786604.SGD","BK0028","BK0239","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409569","title":"股市必读：云南白药（000538）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409569?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:25","pubTimestamp":1790529911,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，云南白药报收于49.87元，下跌0.89%，换手率0.39%，成交量6.94万手，成交额3.47亿元。董秘： 尊敬的投资者您好，截至2026年二季度末，公司股东总数为189,362人。截至2026年二季度末，公司应收账款余额101.83亿元，环比一季度下降14.57%，同比2025年二季度末下降3.15%。云南白药长期投资价值突出，当前股价波动主要受宏观市场环境、市场资金偏好等外部因素影响，存在一定不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1807302812.USD","BK0188","BK0239","BK0196","BK0175","LU1960683339.HKD","BK0012","BK0164","BK0187","LU1993786604.SGD","BK0028","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669842466","title":"云南白药：经营业绩逆势增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2669842466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669842466?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:18","pubTimestamp":1790241499,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药09月24日在投资者关系平台上答复投资者关心的问题。公司锚定战略规划，持续做精主业，用不断提升的运营管理能力应对外部市场的不确定性，经营业绩逆势增长，实现了“增长、增效、增值”的既定目标。云南白药长期投资价值突出，当前股价波动主要受宏观市场环境、市场资金偏好等外部因素影响，存在一定不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400029609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","LU1807302812.USD","BK0012","LU1993786604.SGD","BK0175","BK0196","000538","LU1960683339.HKD","BK0187","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669668184","title":"云南白药：应收账款增加主要来源于商业板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2669668184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669668184?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:15","pubTimestamp":1790241311,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药(000538)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司26年1季报，应收账款大幅增加20亿的原因是什么，是赚的净利润都没有收回来吗？云南白药回复：您好！公司应收账款增加主要来源于商业板块，该板块主要覆盖云南省内公立医院，客户信用较好、应收账款风险较小。截至2026年二季度末，公司应收账款余额101.83亿元，环比一季度下降14.57%，同比2025年二季度末下降3.15%。未来公司将持续强化客户信用全流程闭环管理，有效控制应收账款风险。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400029522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","LU1993786604.SGD","BK0164","LU1807302812.USD","BK0196","BK0028","BK0239","LU1960683339.HKD","BK0012","000538","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669465498","title":"云南白药：截至2026年二季度末，公司股东总数为189,362人","url":"https://stock-news.laohu8.com/highlight/detail?id=2669465498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669465498?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:06","pubTimestamp":1790240767,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药(000538)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月10日深交所下发的股东人数是？云南白药回复：尊敬的投资者您好，截至2026年二季度末，公司股东总数为189,362人。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400029331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1807302812.USD","LU1993786604.SGD","BK0175","BK0188","BK0196","BK0028","BK0012","LU1960683339.HKD","BK0239","BK0187","BK0164","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669414044","title":"云南白药（000538）披露持股5%以上股东可交换债换股价格调整公告，9月22日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414044","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669414044?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:12","pubTimestamp":1790086351,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，云南白药报收于51.32元，较前一交易日上涨0.45%，最新总市值为915.68亿元。近日，云南白药集团股份有限公司披露《关于持股5％以上股东非公开发行可交换公司债券换股价格调整的提示性公告》。因云南白药实施2026年特别分红，向全体股东每10股派发现金红利10.38元（含税），根据债券募集说明书约定，换股价格由70.08元/股调整为69.04元/股，调整自2026年9月24日除权除息日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200041368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1960683339.HKD","BK0187","BK0028","BK0012","BK0188","BK0239","000538","LU1807302812.USD","LU1993786604.SGD","BK0196","BK0175","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125601759","title":"云白国际回购2010万股，释放市场信心信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1125601759","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125601759?lang=zh_cn&edition=full","pubTime":"2026-09-18 23:32","pubTimestamp":1789745552,"startTime":"0","endTime":"0","summary":"9月18日（路透社）——云白国际有限公司于本周发布公告，宣布在2026年9月16日至9月18日期间，累计回购了2010万股公司股份。此举被视为公司管理层对自身价值的高度认可，同时也向市场传递出积极的信号。云白国际此次短时间内的大手笔回购，无疑为当前市场注入了一剂强心针。值得注意的是，这并非云白国际近期的首次回购操作。围绕该公司的更多动态，市场将保持密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000538","BK0196","BK0012","BK0188","BK0164","00030","BK0028","BK1121","LU1993786604.SGD","LU1807302812.USD","BK0175","BK0239","BK1600","LU1960683339.HKD","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668695159","title":"研报掘金丨中邮证券：首予云南白药云南白药，二线品种释放成长驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2668695159","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668695159?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:33","pubTimestamp":1789626783,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["161027","BK0196","BK0175","BK0239","BK0012","BK0187","BK0188","BK0028","LU1993786604.SGD","BK0164","LU1807302812.USD","000538","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668898956","title":"中邮证券：首次覆盖云南白药给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2668898956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668898956?lang=zh_cn&edition=full","pubTime":"2026-09-17 13:00","pubTimestamp":1789621256,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,龙永茂近期对云南白药进行研究并发布了研究报告《营收利润稳健增长，二线品种释放成长驱动力》，首次覆盖云南白药给予买入评级。 盈利预测及投资建议 我们预计公司2026-2028年营收分别为425.71、440.99、456.98亿元，归母净利润分别为53.62、58.05、62.93亿元，当前股价对应PE分别为17、16、14倍，首次覆盖，给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700016793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667981214","title":"云南白药：2026年特别分红权益分派实施公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2667981214","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667981214?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:44","pubTimestamp":1789566240,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月16日，云南白药发布2026年特别分红权益分派实施公告称，公司获股东会审议通过的2026年特别分红具体方案为：以公司现有总股本1,784,262,603股为基数，向全体股东每10股派发现金红利10.38元(含税)，送红股0股，不以资本公积金转增股本，本次现金分红总金额为1,852,064,581.91元。股权登记日为2026年9月23日，除权除息日为2026年9月24日。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-16/doc-inirzwqy9773161.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-16/doc-inirzwqy9773161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0175","BK0164","BK0196","BK0028","LU1960683339.HKD","BK0188","LU1993786604.SGD","BK0187","000538","BK0239","LU1807302812.USD","SHRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667640999","title":"套走6017万港元公款给自己买11只名表，万隆控股前行政总裁周泓获刑10年8个月","url":"https://stock-news.laohu8.com/highlight/detail?id=2667640999","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667640999?lang=zh_cn&edition=full","pubTime":"2026-09-15 21:09","pubTimestamp":1789477788,"startTime":"0","endTime":"0","summary":"红星资本局9月15日消息香港上市公司万隆控股集团（现已更名为云白国际有限公司，00030.HK）一起涉及逾6000万港元的疑似内部欺诈案有新进展。14日，香港高等法院判决万隆控股集团前行政总裁周泓，涉嫌利用职务便利虚构交易、套取公司巨额资金购置名表私用，欺诈罪名成立，判处监禁十年零八个月。法庭同时下令其赔偿公司5157万港元，并禁止其担任公司董事等职务15年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153874977143.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153874977143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0187","BK0188","BK0012","BK0196","000538","BK0164","BK0239","LU1993786604.SGD","LU1807302812.USD","BK0028","BK0175","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666651304","title":"云南白药获得发明专利授权：“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666651304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666651304?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:48","pubTimestamp":1789069739,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示云南白药新获得一项发明专利授权，专利名为“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”，专利申请号为CN202610525250.X，授权日为2026年9月8日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100010280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0175","BK0028","LU1807302812.USD","BK0012","BK0164","LU1993786604.SGD","000538","BK0188","LU1960683339.HKD","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340448","title":"云南白药：9月7日接受机构调研，西部证券、招银理财参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665340448?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:02","pubTimestamp":1788850949,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月7日云南白药发布公告称公司于2026年9月7日接受机构调研，西部证券陆伏崴、招银理财张英 郝雪梅参与。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800018957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0012","BK0183","000538","BK0239","002673","LU1807302812.USD","BK0028","LU1960683339.HKD","BK0188","LU1993786604.SGD","BK0164","BK0175","BK0196","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814770","title":"云南白药上半年营收218.84亿元 拟现金分红18.52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814770","media":"经济参考网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664814770?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:35","pubTimestamp":1788352500,"startTime":"0","endTime":"0","summary":"上半年，公司实现营收218.84亿元，同比增长2.95%；归母净利润37.01亿元，同比增长1.88%，营收与利润保持双增。公司同时公告，拟实施2026年特别分红，现金分红总额18.52亿元。其中，云南白药气雾剂销售收入超15亿元，云南白药膏销售收入超7亿元。云南白药2026年半年报首次披露了聚药堂业绩情况，上半年，聚药堂实现主营业务收入3.18亿元，完成率为51.68%；实现净利润2236.71万元，完成率为37.47%。本次收购前，聚药堂2024年实现营收6.32亿元，净利润6932.83万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-02/doc-iniqmwqq4603531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VIG","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077962","title":"诚通证券：给予云南白药增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077962?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:05","pubTimestamp":1788174343,"startTime":"0","endTime":"0","summary":"诚通证券股份有限公司李志新近期对云南白药进行研究并发布了研究报告《2026年中报业绩点评：整体营收利润双增，二线大单品持续突破》，给予云南白药增持评级。 云南白药 事件： 公司发布2026年中期报告，期内营收利润同比双增。本文数据来源于诚通证券股份有限公司，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100030102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792181909812,"stockEarnings":[{"period":"1week","weight":0.0327},{"period":"1month","weight":0.0656},{"period":"3month","weight":0.0536},{"period":"6month","weight":0.009},{"period":"1year","weight":-0.0333},{"period":"ytd","weight":-0.0171}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"189362人(较上一季度增加11.87%)","perCapita":"9421股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}